Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | 55.00 |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Oct 02 2024 14:05 BST.
More ▼
Press releases
- GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
- GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
- GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint
- GE HealthCare announces cash dividend for third quarter of 2024
- GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 15,000,000 Shares
- GE HealthCare Technologies Inc. Commences Secondary Offering of 10,000,000 Shares
- GE HealthCare Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments at the Point of Care at ESC 2024
- GE HealthCare management to present at September investor conferences
- Clinical Study Shows Targeted End-tidal Control Anesthesia Delivery Improves Efficiency and Accuracy to Help Optimize Patient Care
- GE HealthCare to Embark on a Collaboration to Elevate Women’s Imaging
More ▼